477726-77-5
中文名称
化合物 BMI-1026
英文名称
2,4-Bis-(2-aMino-pyriMidin-4-yl)-phenol
CAS
477726-77-5
分子式
C14H12N6O
分子量
280.28
MOL 文件
477726-77-5.mol
结构式
物理化学性质
| 沸点 | 651.8±65.0 °C(Predicted) |
| 密度 | 1.430±0.06 g/cm3(Predicted) |
| 酸度系数(pKa) | 6.49±0.50(Predicted) |
应用领域
用途一
BMI-1026 is a potent cdk inhibitor with potential anticancer activity. BMI-1026 induced a strong cell cycle alteration with potent inhibitory activities against cyclin-dependent kinases, collectively known as Cdks. BMI-1026 imposes a potent G(2)-M arrest and mild G(1)-S and S arrests. In vitro BMI-1026 induces a mitotic catastrophe and precocious mitotic exit even in the presence of nocodazole. These defects appeared to lead to apoptotic cell death in tumorigenic cell lines. Consistent with the induction of mitotic defects and apoptosis, BMI-1026 imposed a selective sensitivity to proliferating versus differentiating or growth-arrested mouse keratinocytes. These data suggest that BMI-1026 could be developed as a potential anti-Cdk1 chemotherapeutic agent.
常见问题列表
概述
BMI-1026 是一种周期蛋白依赖性激酶 1 (Cdk1) 抑制剂，IC50 为 2.3 nM。BMI-1026 通过阻滞 G2-M 期诱导细胞凋亡 (apoptosis)。